Patents Assigned to OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU "NORMOFARM"
  • Publication number: 20200009111
    Abstract: The agent with antistress, anxiolytic and antidepressant activity and a composition based on it. The invention relates to the field of pharmaceutics, particularly to chemical compounds based on lithium salts, namely to substances with antistress, anxiolytic and antidepressant activity and can be used in medicine, veterinary medicine, and the pharmaceutical industry. The invention discovers the possibility of using lithium ascorbate as an agent with antistress, anxiolytic and antidepressant activity. The claimed composition with antistress, anxiolytic and antidepressant activity, including a lithium salt, contains pyridoxine hydrochloride, thiamine mononitrate and lithium ascorbate as a lithium salt. The use of lithium ascorbate as an agent with antistress, anxiolytic and antidepressant action and the composition based on it, enables to expand the assortment of the agents for indicated administration. At the same time, the claimed agents have low toxicity and high efficacy.
    Type: Application
    Filed: September 17, 2019
    Publication date: January 9, 2020
    Applicant: OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU "NORMOFARM"
    Inventors: Viacheslav Valerievich RASTASHANSKIY, Konstantin Sergeevich OSTRENKO
  • Publication number: 20180228766
    Abstract: The agent with antistress, anxiolytic and antidepressant activity and a composition based on it. The invention relates to the field of pharmaceutics, particularly to chemical compounds based on lithium salts, namely to substances with antistress, anxiolytic and antidepressant activity and can be used in medicine, veterinary medicine, and the pharmaceutical industry. The invention discovers the possibility of using lithium ascorbate as an agent with antistress, anxiolytic and antidepressant activity. The claimed composition with antistress, anxiolytic and antidepressant activity, including a lithium salt, contains pyridoxine hydrochloride, thiamine mononitrate and lithium ascorbate as a lithium salt. The use of lithium ascorbate as an agent with antistress, anxiolytic and antidepressant action and the composition based on it, enables to expand the assortment of the agents for indicated administration. At the same time, the claimed agents have low toxicity and high efficacy.
    Type: Application
    Filed: April 11, 2018
    Publication date: August 16, 2018
    Applicant: OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU "NORMOFARM"
    Inventors: Viacheslav Valerievich RASTASHANSKIY, Konstantin Sergeevich OSTRENKO